Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2

Conditions

Recurrence 2Polycystic Ovary Syndrome 2Pleural Effusion, Malignant 2Neoplasms 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Triple Negative Breast Neoplasms 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

aldesleukin 2Trastuzumab 2Pharmaceutical Preparations 2Interleukin-2 2Carboplatin 2Bevacizumab 2tocilizumab 1tipifarnib 1romidepsin 1lipoplatin 1Verteporfin 1Valacyclovir 1Tyrosine Kinase Inhibitors 1Sorafenib 1SPI-77, liposomal 1Povidone-Iodine 1Pleurodesis 1Photochemotherapy 1Paclitaxel 1LMB-100 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunotherapy, Adoptive 1Gemcitabine 1Erlotinib Hydrochloride 1Docetaxel 1Decitabine 1Dasatinib 1Cytoreduction Surgical Procedures 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Pleural Effusion, Malignant × Pharmaceutical Preparations × Clear all
NCT07443020 2026-04-07

RIOT 4B

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting
10 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT07192900 2026-01-15

(RIOT 4A)

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting
10 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡